TY  - ADVS
AU  - Brown,Bob
TI  - Epigenetic biomarkers in cancer
T2  - Biomarkers : the path forward to highly sensitive and specific molecular diagnostics,
PY  - 2012///
CY  - London
PB  - Henry Stewart Talks
KW  - Cancer
KW  - Genetic aspects
KW  - DNA
KW  - Methylation
KW  - Epigenesis
KW  - Tumor markers
KW  - DNA Methylation
KW  - Epigenesis, Genetic
KW  - Neoplasms
KW  - drug therapy
KW  - genetics
KW  - Tumor Markers, Biological
N1  - Animated audio-visual presentation with synchronized narration; Title from title frames; Contents: Epigenetics -- levels of control -- The patient cancer journey-multiple impact points -- Key translational areas for epigenetics -- DNA methylation as cancer biomarker -- DNA methylation analysis methods -- Epigenetic gene silencing in malignant cells -- CpG methylation and clinical outcome -- Causes of aberrant DNA methylation in cancer -- Stem cell targets -- EZH2 as a potential anti-cancer target -- Epigenetic modification as drug targets -- Epigenetic therapies -- DNA methylation versus platinum resistance -- Phase II trial of Decitabine & Carboplatin -- Effects of low doses of DNA-demethylation agents -- Epigenetic therapies challenges; Access restricted to subscribers
UR  - https://hstalks.com/bs/2401/
UR  - https://hstalks.com/bs/p/666/
ER  -